Tuesday, July 08, 2008
« Lighting and Optical Tools for Image For... | Main | The Journal of Web Librarianship »
Fluoroquinolones: Boxed Warning to be added for risk of tendon rupture and tendinitis
FDA notified healthcare professionals that a BOXED WARNING and Medication Guide are to be added to the prescribing information to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use.

This risk of tendinitis and tendon rupture is further increased in those over age 60, in kidney, heart, and lung transplant recipients, and with use of concomitant steroid therapy. Physicians should advise patients, at the first sign of tendon pain, swelling, or inflammation, to stop taking the fluoroquinolone, to avoid exercise and use of the affected area, and to promptly contact their doctor about changing to a non-fluoroquinolone antimicrobial drug. Selection of a fluoroquinolone for the treatment or prevention of an infection should be limited to those conditions that are proven or strongly suspected to be caused by bacteria.

Read the complete MedWatch 2008 Safety Summary, including a link to the 'Information for Healthcare Professionals' page, at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Fluoroquinolone

Science
Tuesday, July 08, 2008 2:38:19 PM (Eastern Daylight Time, UTC-04:00)    Disclaimer  |  Comments [0]  |  Related posts:
Americans can not read so they do not know when they are being taken
Euro Pacific Capital president Peter Schiff's accurate predictions in 2006 and 2007 about the economic meltdown
Build a wireless Finger Phone
Tunnelling nanotubes: Life's secret network
Send your Message in a space time capsule which will be launched in 2010 or 2011
ECP NetHappenings News and Headlines